Journal article 974 views 122 downloads
Early Treatment with Basal Insulin Glargine in People with Type 2 Diabetes: Lessons from ORIGIN and Other Cardiovascular Trials
Diabetes Therapy, Volume: 7, Issue: 2, Pages: 187 - 201
Swansea University Author: David Owens
-
PDF | Version of Record
Open Access. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Download (664.33KB)
DOI (Published version): 10.1007/s13300-016-0153-3
Abstract
Early Treatment with Basal Insulin Glargine in People with Type 2 Diabetes: Lessons from ORIGIN and Other Cardiovascular Trials
Published in: | Diabetes Therapy |
---|---|
ISSN: | 1869-6961 |
Published: |
2016
|
Online Access: |
Check full text
|
URI: | https://cronfa.swan.ac.uk/Record/cronfa26162 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
first_indexed |
2016-02-12T01:59:06Z |
---|---|
last_indexed |
2020-07-21T12:41:07Z |
id |
cronfa26162 |
recordtype |
SURis |
fullrecord |
<?xml version="1.0"?><rfc1807><datestamp>2020-07-21T11:29:02.0742182</datestamp><bib-version>v2</bib-version><id>26162</id><entry>2016-02-11</entry><title>Early Treatment with Basal Insulin Glargine in People with Type 2 Diabetes: Lessons from ORIGIN and Other Cardiovascular Trials</title><swanseaauthors><author><sid>2fd4b7c3f82c6d3bd546eff61ff944e9</sid><ORCID>0000-0003-1002-1238</ORCID><firstname>David</firstname><surname>Owens</surname><name>David Owens</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2016-02-11</date><deptcode>BMS</deptcode><abstract/><type>Journal Article</type><journal>Diabetes Therapy</journal><volume>7</volume><journalNumber>2</journalNumber><paginationStart>187</paginationStart><paginationEnd>201</paginationEnd><publisher/><issnElectronic>1869-6961</issnElectronic><keywords/><publishedDay>30</publishedDay><publishedMonth>6</publishedMonth><publishedYear>2016</publishedYear><publishedDate>2016-06-30</publishedDate><doi>10.1007/s13300-016-0153-3</doi><url/><notes/><college>COLLEGE NANME</college><department>Biomedical Sciences</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>BMS</DepartmentCode><institution>Swansea University</institution><degreesponsorsfunders>Sanofi (Commercial Company)</degreesponsorsfunders><apcterm/><lastEdited>2020-07-21T11:29:02.0742182</lastEdited><Created>2016-02-11T11:17:28.5492197</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Markolf</firstname><surname>Hanefeld</surname><order>1</order></author><author><firstname>Louis</firstname><surname>Monnier</surname><order>2</order></author><author><firstname>Oliver</firstname><surname>Schnell</surname><order>3</order></author><author><firstname>David</firstname><surname>Owens</surname><orcid>0000-0003-1002-1238</orcid><order>4</order></author></authors><documents><document><filename>26162__2738__dc0eedc66b4a43fba960d554e8321ea7.pdf</filename><originalFilename>OwensEarlytreatment2016VOROA.pdf</originalFilename><uploaded>2016-04-07T17:45:21.9170000</uploaded><type>Output</type><contentLength>680269</contentLength><contentType>application/pdf</contentType><version>Version of Record</version><cronfaStatus>true</cronfaStatus><embargoDate>2016-04-07T00:00:00.0000000</embargoDate><documentNotes>Open Access. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.</documentNotes><copyrightCorrect>true</copyrightCorrect></document></documents><OutputDurs/></rfc1807> |
spelling |
2020-07-21T11:29:02.0742182 v2 26162 2016-02-11 Early Treatment with Basal Insulin Glargine in People with Type 2 Diabetes: Lessons from ORIGIN and Other Cardiovascular Trials 2fd4b7c3f82c6d3bd546eff61ff944e9 0000-0003-1002-1238 David Owens David Owens true false 2016-02-11 BMS Journal Article Diabetes Therapy 7 2 187 201 1869-6961 30 6 2016 2016-06-30 10.1007/s13300-016-0153-3 COLLEGE NANME Biomedical Sciences COLLEGE CODE BMS Swansea University Sanofi (Commercial Company) 2020-07-21T11:29:02.0742182 2016-02-11T11:17:28.5492197 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Markolf Hanefeld 1 Louis Monnier 2 Oliver Schnell 3 David Owens 0000-0003-1002-1238 4 26162__2738__dc0eedc66b4a43fba960d554e8321ea7.pdf OwensEarlytreatment2016VOROA.pdf 2016-04-07T17:45:21.9170000 Output 680269 application/pdf Version of Record true 2016-04-07T00:00:00.0000000 Open Access. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. true |
title |
Early Treatment with Basal Insulin Glargine in People with Type 2 Diabetes: Lessons from ORIGIN and Other Cardiovascular Trials |
spellingShingle |
Early Treatment with Basal Insulin Glargine in People with Type 2 Diabetes: Lessons from ORIGIN and Other Cardiovascular Trials David Owens |
title_short |
Early Treatment with Basal Insulin Glargine in People with Type 2 Diabetes: Lessons from ORIGIN and Other Cardiovascular Trials |
title_full |
Early Treatment with Basal Insulin Glargine in People with Type 2 Diabetes: Lessons from ORIGIN and Other Cardiovascular Trials |
title_fullStr |
Early Treatment with Basal Insulin Glargine in People with Type 2 Diabetes: Lessons from ORIGIN and Other Cardiovascular Trials |
title_full_unstemmed |
Early Treatment with Basal Insulin Glargine in People with Type 2 Diabetes: Lessons from ORIGIN and Other Cardiovascular Trials |
title_sort |
Early Treatment with Basal Insulin Glargine in People with Type 2 Diabetes: Lessons from ORIGIN and Other Cardiovascular Trials |
author_id_str_mv |
2fd4b7c3f82c6d3bd546eff61ff944e9 |
author_id_fullname_str_mv |
2fd4b7c3f82c6d3bd546eff61ff944e9_***_David Owens |
author |
David Owens |
author2 |
Markolf Hanefeld Louis Monnier Oliver Schnell David Owens |
format |
Journal article |
container_title |
Diabetes Therapy |
container_volume |
7 |
container_issue |
2 |
container_start_page |
187 |
publishDate |
2016 |
institution |
Swansea University |
issn |
1869-6961 |
doi_str_mv |
10.1007/s13300-016-0153-3 |
college_str |
Faculty of Medicine, Health and Life Sciences |
hierarchytype |
|
hierarchy_top_id |
facultyofmedicinehealthandlifesciences |
hierarchy_top_title |
Faculty of Medicine, Health and Life Sciences |
hierarchy_parent_id |
facultyofmedicinehealthandlifesciences |
hierarchy_parent_title |
Faculty of Medicine, Health and Life Sciences |
department_str |
Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine |
document_store_str |
1 |
active_str |
0 |
published_date |
2016-06-30T03:31:17Z |
_version_ |
1763751260311257088 |
score |
11.037056 |